Ling Bi

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Neural Stem Cells

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Cancer research

Journal of cellular and molecular medicine

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Ming-Yu Luo, Ye Zhou, Wei-Ming Gu, Cheng Wang, Ning-Xiang Shen, Jiang-Kai Dong, Hui-Min Lei, Ya-Bin Tang, Qian Liang, Jing-Hua Zou, Lu Xu, Pengfei Ma, Guanglei Zhuang, Ling Bi, Ling Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. Cancer research 82 (19) (2022)
Rongzhen Ding, Lijing Jiao, Shuliu Sang, Yinan Yin, Yichao Wang, Yabin Gong, Ling Xu, Ling Bi
Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Ling Bi, Chanlu Xie, Lijing Jiao, Shenyi Jin, Su Su Thae Hnit, Yao Mu, Yilun Wang, Qian Wang, Guangbo Ge, Yaqiao Wang, Xiao-Dong Zhao, Xinglong Shi, Yani Kang, Paul De Souza, Tao Liu, Jia Zhou, Ling Xu, Qihan Dong
CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC. Journal of cellular and molecular medicine 24 (3) (2020)